UnitedHealth Group, the nation’s largest private insurer, announced third-quarter results on Tuesday that surpassed analyst estimates and prompted the company to increase its full-year profit outlook. The revised fiscal 2026 adjusted earnings guidance was raised to at least $20.50 per share from a previous range of $19.50 to $20 per share.
The company posted third-quarter net income of $4.11 billion, or $4.56 per share, compared with $2.35 billion, or $2.59 per share, in the prior-year period. On an adjusted basis excluding divestitures, restructuring charges, and reserve reductions for unprofitable contracts, the company earned $4.69 per share. Revenue declined to $112.69 billion from $113.16 billion year over year. Both the UnitedHealthcare insurer unit and its Optum healthcare division exceeded operating earnings expectations for the quarter according to analyst tracking.
A key metric showing operational improvement was the medical cost ratio, which reached 88.4% for the quarter against analyst expectations of 89.9%. This ratio measures total medical expenses relative to premiums collected, with lower figures indicating stronger profitability. However, company leadership cautioned that medical costs remained elevated compared to historical averages. Chief Financial Officer Wayne DeVeydt noted that the independent dispute resolution process mandated under federal law is adding approximately 100 basis points to total medical costs, while inpatient services and specialty pharmacy expenses also remain high.
The company’s turnaround strategy centers on stabilizing profit margins through membership reduction, exiting unprofitable contracts, and expanding investments in value-based care and artificial intelligence. Value-based care arrangements tie provider compensation to patient outcomes and cost-effectiveness rather than service volume. Early results showed acute hospital admissions among company members declined 15% year over year through the third quarter, while home health admissions increased 10%, indicating a shift toward lower-cost care settings. The company is also implementing AI tools to reduce physician administrative tasks and reported a 27% year-over-year increase in patient-initiated appointment scheduling.
Company shares rose approximately 3% in premarket trading following the announcement. Leadership indicated these initiatives are expected to produce compounding benefits for medical cost management through the remainder of the year and into the following year as programs scale up.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI